<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87531">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02154451</url>
  </required_header>
  <id_info>
    <org_study_id>10-304</org_study_id>
    <nct_id>NCT02154451</nct_id>
  </id_info>
  <brief_title>Transient Infrared Imaging for Early Detection of Skin Cancer</brief_title>
  <official_title>Transient Infrared Imaging for Early Detection of Skin Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skinfrared LLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skinfrared LLC</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis or study goal is to determine whether functional dynamic infrared imaging can
      be used for melanoma and other skin cancer screening and/or diagnosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>To detect skin cancers with &gt;90% sensitivity and &gt;50% specificity using infrared imaging</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>We are developing a screening algorithm than can compute data from infrared pictures and give us a threshold below which all the cases are benign and above which is malignant.
Our primary outcome is to detect all the malignant cases with more than 90% sensitivity and all the benign cases with more than 50% specificity,</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Skin Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Infrared Imaging Device- ALIAS</intervention_name>
    <description>Infrared Camera</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All lesion in easily accessible places

          -  Lesion less than 3.5 cm

        Exclusion Criteria:

          -  Any minors

          -  Lesion close to vital organs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Sanchita krishna, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skinfrared LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sanchita Krishna, PhD</last_name>
    <phone>505 453 3349</phone>
    <email>sanchita@skinfrared.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of new Mexico, Dermatology clinic</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanchita Krishna, PhD</last_name>
      <phone>505-453-3349</phone>
      <email>sanchita@skinfrared.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Univesity of New Mexico, Derm Clinic</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanchita Krishna, PhD</last_name>
      <phone>505-453-3349</phone>
      <email>sanchita@skinfrared.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of New Mexico, Derm Clinic</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanchita Krishna, PhD</last_name>
      <phone>505-453-3349</phone>
      <email>sanchita@skinfrared.com</email>
    </contact>
    <investigator>
      <last_name>Steve Padilla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>May 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
